H & T Presspart, Hovione ink commercialization deal for inhaler tech

H&T Presspart said this week that it acquired the global rights to Hovione Technology‘s capsule-based dry powder inhaler. The company launched a next-gen version of the inhaler called PowdAir Plus at this year’s Respiratory Drug Delivery Europe. The PowdAir Plus device is made of plastic and its 4-component design lessens manufacturing, assembly and production costs, according to H&T Presspart. Get the full story at our sister site, Drug Delivery Business News. The post H&T Presspart, Hovione ink commercialization deal for inhaler tech appeared first on MassDevice.
Source: Mass Device - Category: Medical Equipment Authors: Tags: Drug-Device Combinations Pharmaceuticals Respiratory Wall Street Beat H&T Presspart Hovione Technology Source Type: news